Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Johnson & Johnson to stop sales of baby powder in US and Canada amid cancer lawsuits

New Jersey-based firm faces thousands of lawsuits amid claims about alleged cancer risks

Gino Spocchia
Wednesday 20 May 2020 08:08 BST
Comments
Doctor slams Donald Trump taking hydroxychloroquine as 'dangerous'

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Johnson & Johnson will stop selling talc-based Johnson’s Baby Powder in the US and Canada, where demand has dwindled amid thousands of lawsuits claiming it has caused cancer.

The international pharmaceuticals producer said the talc-based powder will still be sold outside the US and Canada.

“Demand for talc-based Johnson’s Baby Powder in North America has been declining due in large part to changes in consumer habits and fuelled by misinformation around the safety of the product and a constant barrage of litigation advertising,” the company said.

The health care company faces about 19,400 lawsuits that allege its talcum powder has caused ovarian cancer in users.

J&J maintains that its products are safe, and that the decision was also made based on consumer demands during the Covid-19 pandemic.

“Whether or not the powder actually causes cancer, people became hesitant to use the product,” said Erik Gordon, a professor at University of Michigan’s business school, said in an email.

J&J spokeswoman Kimberly Montagnino said the company doesn’t plan to settle any of the lawsuits and “will continue to vigorously defend” the product.

The New Brunswick, New Jersey, company said the baby powder decision came as it moves to discontinue about 100 consumer health products in a bid to prioritise making products people want.

J&J will still sell cornstarch-based baby powder in North America.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in